CMO
Cosmo Metals Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-30.64%
Annual Growth
3 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Cosmo Metals Ltd. engages in the metal exploration business. The firm is focused on the advancement of its flagship Mt Venn, Winchester and Eastern Mafic projects in the underexplored Yamarna Belt, in the Eastern Goldfields region of Western Australia. Its projects in the Yamarna Region are located approximately 130 kilometers (km) east of Laverton in the Eastern Goldfields District of Western Australia. The Company’s Yamarna landholding immediately west of the 6.7Moz Gruyere gold mine comprises nine granted exploration licenses, two prospecting leases and two exploration license applications in three separate areas. The Winchester exploration area is located to the north of the Yamarna exploration area and consists of two tenements covering 91 square kilometers (km2). The company also has two other tenement applications in the southern Wheatbelt region of Western Australia. The Pingrup applications E70/5955 (6 blocks) and E70/5956 (16 blocks) overlie farmland south of Lake Grace.
📈 Performance
Price History
-89.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.02
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CMO
2
📊 Total Capital Earnings
$-660.486
🔃 Average investment frequency
17 weeks
💵 Average investment amount
$3,221
⏰ Last time a customer invested in CMO
145 days
CMO investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
Less than 50k
50%
👶 Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
🙋 Legal gender of investors
Female
50%
Male
50%
Pearlers who invest in CMO also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.63%
📊 Share price
$102.10 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. The company is headquartered in Melbourne, Victoria. The company went IPO on 2005-02-03. The firm is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The firm has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.
🙌 Performance (5Yr p.a)
83.91%
📊 Share price
$12.21 AUD
📦 LOGISTICS
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
🙌 Performance (5Yr p.a)
9.25%
📊 Share price
$36.29 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
🩺 HEALTH CARE
📈 HIGH PRICE GROWTH
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
14.07%
📊 Share price
$140.20 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
🤖 TECHNOLOGY
QUAL.AX was created on 2014-10-29 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
🙌 Performance (5Yr p.a)
18.02%
📊 Share price
$58.46 AUD
🤖 TECHNOLOGY
🌏 GLOBAL
🩺 HEALTH CARE
📈 HIGH PRICE GROWTH
📞 COMMUNICATIONS
Want more shares? Try these...
Compumedics Ltd. engages in the research, development, manufacture, and distribution of medical equipment and associated technologies. The company is headquartered in Melbourne, Victoria and currently employs 155 full-time employees. The company went IPO on 2000-12-21. Its geographic segments include Americas, Australia and Asia Pacific, and Europe and the Middle East. The company sells all of its product offerings in this region, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. The company provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. The company offers Brain Research technologies through the Compumedics Neuroscan brand. Compumedics Neuroscan technologies provide solutions for EEG, ERPs, Source Localization and Functional Neuroimaging. The company also provides solutions for sleep applications from high definition 4k full PSG to home sleep testing.
🙌 Performance (5Yr p.a)
-13.25%
📊 Share price
$0.27 AUD
🩺 HEALTH CARE
Capricorn Metals Ltd. engages in the mineral and gold exploration, development, and project evaluation. The company is headquartered in Perth, Western Australia. The company went IPO on 2008-07-07. The firm exploration, evaluation, development and production at the Karlawinda Gold Project and exploration and evaluation of the Mt Gibson Gold Project. The Karlawinda Gold Project located in the Pilbara region of Western Australia, 65 kilometers (km) south-east of the town of Newman. The Karlawinda Project consists of over 2,000 square kilometers of prospective tenure which includes the greenstone belt hosting the 2.2-million-ounce Resource and 1.2-million-ounce Reserve Bibra gold deposit and other areas deemed prospective for gold. The Mt Gibson Gold Project (MGGP) is located approximately 280 kilometers northeast of Perth and less than 10 kilometers from the main arterial Great Northern Highway, in the Murchison region of Western Australia. The company is 150 kilometers south-southeast (SSE) of Yalgoo (Golden Grove VHMS base metal deposits) and 240 kilometers south-southwest (SSW) of Cue and the Big Bell and other lode gold mines.
🙌 Performance (5Yr p.a)
87.83%
📊 Share price
$6.47 AUD
⛏️ MINING